RFID Reader
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
Global Pharmaceutical Intermediates Market Outlook 2023
1 Pharmaceutical Intermediates Market Overview
1.1 Product Overview and Scope of Pharmaceutical Intermediates
1.2 Pharmaceutical Intermediates Segment by Type
1.2.1 Global Pharmaceutical Intermediates Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 GMP
1.2.3 Non-GMP
1.3 Pharmaceutical Intermediates Segment by Application
1.3.1 Global Pharmaceutical Intermediates Sales Comparison by Application: (2021-2027)
1.3.2 Antibiotics
1.3.3 Antipyretic Analgesics
1.3.4 Vitamins
1.3.5 Others
1.4 Global Pharmaceutical Intermediates Market Size Estimates and Forecasts
1.4.1 Global Pharmaceutical Intermediates Revenue 2016-2027
1.4.2 Global Pharmaceutical Intermediates Sales 2016-2027
1.4.3 Pharmaceutical Intermediates Market Size by Region: 2016 Versus 2021 Versus 2027
2 Pharmaceutical Intermediates Market Competition by Manufacturers
2.1 Global Pharmaceutical Intermediates Sales Market Share by Manufacturers (2016-2021)
2.2 Global Pharmaceutical Intermediates Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Pharmaceutical Intermediates Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Pharmaceutical Intermediates Manufacturing Sites, Area Served, Product Type
2.5 Pharmaceutical Intermediates Market Competitive Situation and Trends
2.5.1 Pharmaceutical Intermediates Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Pharmaceutical Intermediates Players Market Share by Revenue
2.5.3 Global Pharmaceutical Intermediates Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pharmaceutical Intermediates Retrospective Market Scenario by Region
3.1 Global Pharmaceutical Intermediates Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Pharmaceutical Intermediates Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Pharmaceutical Intermediates Market Facts & Figures by Country
3.3.1 North America Pharmaceutical Intermediates Sales by Country
3.3.2 North America Pharmaceutical Intermediates Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Pharmaceutical Intermediates Market Facts & Figures by Country
3.4.1 Europe Pharmaceutical Intermediates Sales by Country
3.4.2 Europe Pharmaceutical Intermediates Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Pharmaceutical Intermediates Market Facts & Figures by Region
3.5.1 Asia Pacific Pharmaceutical Intermediates Sales by Region
3.5.2 Asia Pacific Pharmaceutical Intermediates Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Pharmaceutical Intermediates Market Facts & Figures by Country
3.6.1 Latin America Pharmaceutical Intermediates Sales by Country
3.6.2 Latin America Pharmaceutical Intermediates Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Pharmaceutical Intermediates Market Facts & Figures by Country
3.7.1 Middle East and Africa Pharmaceutical Intermediates Sales by Country
3.7.2 Middle East and Africa Pharmaceutical Intermediates Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Pharmaceutical Intermediates Historic Market Analysis by Type
4.1 Global Pharmaceutical Intermediates Sales Market Share by Type (2016-2021)
4.2 Global Pharmaceutical Intermediates Revenue Market Share by Type (2016-2021)
4.3 Global Pharmaceutical Intermediates Price by Type (2016-2021)
5 Global Pharmaceutical Intermediates Historic Market Analysis by Application
5.1 Global Pharmaceutical Intermediates Sales Market Share by Application (2016-2021)
5.2 Global Pharmaceutical Intermediates Revenue Market Share by Application (2016-2021)
5.3 Global Pharmaceutical Intermediates Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Lonza
6.1.1 Lonza Corporation Information
6.1.2 Lonza Description and Business Overview
6.1.3 Lonza Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Lonza Pharmaceutical Intermediates Product Portfolio
6.1.5 Lonza Recent Developments/Updates
6.2 Catalent
6.2.1 Catalent Corporation Information
6.2.2 Catalent Description and Business Overview
6.2.3 Catalent Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Catalent Pharmaceutical Intermediates Product Portfolio
6.2.5 Catalent Recent Developments/Updates
6.3 Patheon
6.3.1 Patheon Corporation Information
6.3.2 Patheon Description and Business Overview
6.3.3 Patheon Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Patheon Pharmaceutical Intermediates Product Portfolio
6.3.5 Patheon Recent Developments/Updates
6.4 Jubilant
6.4.1 Jubilant Corporation Information
6.4.2 Jubilant Description and Business Overview
6.4.3 Jubilant Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Jubilant Pharmaceutical Intermediates Product Portfolio
6.4.5 Jubilant Recent Developments/Updates
6.5 Granules
6.5.1 Granules Corporation Information
6.5.2 Granules Description and Business Overview
6.5.3 Granules Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Granules Pharmaceutical Intermediates Product Portfolio
6.5.5 Granules Recent Developments/Updates
6.6 Ganesh
6.6.1 Ganesh Corporation Information
6.6.2 Ganesh Description and Business Overview
6.6.3 Ganesh Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Ganesh Pharmaceutical Intermediates Product Portfolio
6.6.5 Ganesh Recent Developments/Updates
6.7 Chemcon
6.6.1 Chemcon Corporation Information
6.6.2 Chemcon Description and Business Overview
6.6.3 Chemcon Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Chemcon Pharmaceutical Intermediates Product Portfolio
6.7.5 Chemcon Recent Developments/Updates
6.8 BASF
6.8.1 BASF Corporation Information
6.8.2 BASF Description and Business Overview
6.8.3 BASF Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
6.8.4 BASF Pharmaceutical Intermediates Product Portfolio
6.8.5 BASF Recent Developments/Updates
6.9 Porton
6.9.1 Porton Corporation Information
6.9.2 Porton Description and Business Overview
6.9.3 Porton Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Porton Pharmaceutical Intermediates Product Portfolio
6.9.5 Porton Recent Developments/Updates
6.10 Lianhetech
6.10.1 Lianhetech Corporation Information
6.10.2 Lianhetech Description and Business Overview
6.10.3 Lianhetech Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Lianhetech Pharmaceutical Intermediates Product Portfolio
6.10.5 Lianhetech Recent Developments/Updates
6.11 ABA Chem
6.11.1 ABA Chem Corporation Information
6.11.2 ABA Chem Pharmaceutical Intermediates Description and Business Overview
6.11.3 ABA Chem Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
6.11.4 ABA Chem Pharmaceutical Intermediates Product Portfolio
6.11.5 ABA Chem Recent Developments/Updates
6.12 Tianma
6.12.1 Tianma Corporation Information
6.12.2 Tianma Pharmaceutical Intermediates Description and Business Overview
6.12.3 Tianma Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Tianma Pharmaceutical Intermediates Product Portfolio
6.12.5 Tianma Recent Developments/Updates
6.13 Jiujiujiu
6.13.1 Jiujiujiu Corporation Information
6.13.2 Jiujiujiu Pharmaceutical Intermediates Description and Business Overview
6.13.3 Jiujiujiu Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Jiujiujiu Pharmaceutical Intermediates Product Portfolio
6.13.5 Jiujiujiu Recent Developments/Updates
6.14 Alpha
6.14.1 Alpha Corporation Information
6.14.2 Alpha Pharmaceutical Intermediates Description and Business Overview
6.14.3 Alpha Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Alpha Pharmaceutical Intermediates Product Portfolio
6.14.5 Alpha Recent Developments/Updates
6.15 Jiuzhou
6.15.1 Jiuzhou Corporation Information
6.15.2 Jiuzhou Pharmaceutical Intermediates Description and Business Overview
6.15.3 Jiuzhou Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Jiuzhou Pharmaceutical Intermediates Product Portfolio
6.15.5 Jiuzhou Recent Developments/Updates
6.16 Yongtai
6.16.1 Yongtai Corporation Information
6.16.2 Yongtai Pharmaceutical Intermediates Description and Business Overview
6.16.3 Yongtai Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Yongtai Pharmaceutical Intermediates Product Portfolio
6.16.5 Yongtai Recent Developments/Updates
7 Pharmaceutical Intermediates Manufacturing Cost Analysis
7.1 Pharmaceutical Intermediates Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Pharmaceutical Intermediates
7.4 Pharmaceutical Intermediates Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Pharmaceutical Intermediates Distributors List
8.3 Pharmaceutical Intermediates Customers
9 Pharmaceutical Intermediates Market Dynamics
9.1 Pharmaceutical Intermediates Industry Trends
9.2 Pharmaceutical Intermediates Growth Drivers
9.3 Pharmaceutical Intermediates Market Challenges
9.4 Pharmaceutical Intermediates Market Restraints
10 Global Market Forecast
10.1 Pharmaceutical Intermediates Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Pharmaceutical Intermediates by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Pharmaceutical Intermediates by Type (2022-2027)
10.2 Pharmaceutical Intermediates Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Pharmaceutical Intermediates by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Pharmaceutical Intermediates by Application (2022-2027)
10.3 Pharmaceutical Intermediates Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Pharmaceutical Intermediates by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Pharmaceutical Intermediates by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Pharmaceutical Intermediates Sales (K MT) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Pharmaceutical Intermediates Sales (K MT) Comparison by Application (2021-2027)
Table 3. Global Pharmaceutical Intermediates Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Pharmaceutical Intermediates Covered in This Study
Table 5. Global Pharmaceutical Intermediates Sales (K MT) of Key Manufacturers (2016-2021)
Table 6. Global Pharmaceutical Intermediates Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Pharmaceutical Intermediates Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Pharmaceutical Intermediates Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Pharmaceutical Intermediates Average Price (USD/MT) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Pharmaceutical Intermediates Manufacturing Sites and Area Served
Table 11. Manufacturers Pharmaceutical Intermediates Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Pharmaceutical Intermediates by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical Intermediates as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Pharmaceutical Intermediates Sales by Region (2016-2021) & (K MT)
Table 16. Global Pharmaceutical Intermediates Sales Market Share by Region (2016-2021)
Table 17. Global Pharmaceutical Intermediates Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Pharmaceutical Intermediates Sales by Country (2016-2021) & (K MT)
Table 19. North America Pharmaceutical Intermediates Sales Market Share by Country (2016-2021)
Table 20. North America Pharmaceutical Intermediates Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Pharmaceutical Intermediates Revenue Market Share by Country (2016-2021)
Table 22. Europe Pharmaceutical Intermediates Sales by Country (2016-2021) & (K MT)
Table 23. Europe Pharmaceutical Intermediates Sales Market Share by Country (2016-2021)
Table 24. Europe Pharmaceutical Intermediates Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Pharmaceutical Intermediates Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Pharmaceutical Intermediates Sales by Region (2016-2021) & (K MT)
Table 27. Asia Pacific Pharmaceutical Intermediates Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Pharmaceutical Intermediates Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Pharmaceutical Intermediates Revenue Market Share by Region (2016-2021)
Table 30. Latin America Pharmaceutical Intermediates Sales by Country (2016-2021) & (K MT)
Table 31. Latin America Pharmaceutical Intermediates Sales Market Share by Country (2016-2021)
Table 32. Latin America Pharmaceutical Intermediates Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Pharmaceutical Intermediates Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Pharmaceutical Intermediates Sales by Country (2016-2021) & (K MT)
Table 35. Middle East and Africa Pharmaceutical Intermediates Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Pharmaceutical Intermediates Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Pharmaceutical Intermediates Revenue Market Share by Country (2016-2021)
Table 38. Global Pharmaceutical Intermediates Sales (K MT) by Type (2016-2021)
Table 39. Global Pharmaceutical Intermediates Sales Market Share by Type (2016-2021)
Table 40. Global Pharmaceutical Intermediates Revenue (Million US$) by Type (2016-2021)
Table 41. Global Pharmaceutical Intermediates Revenue Share by Type (2016-2021)
Table 42. Global Pharmaceutical Intermediates Price (USD/MT) by Type (2016-2021)
Table 43. Global Pharmaceutical Intermediates Sales (K MT) by Application (2016-2021)
Table 44. Global Pharmaceutical Intermediates Sales Market Share by Application (2016-2021)
Table 45. Global Pharmaceutical Intermediates Revenue (Million US$) by Application (2016-2021)
Table 46. Global Pharmaceutical Intermediates Revenue Share by Application (2016-2021)
Table 47. Global Pharmaceutical Intermediates Price (USD/MT) by Application (2016-2021)
Table 48. Lonza Corporation Information
Table 49. Lonza Description and Business Overview
Table 50. Lonza Pharmaceutical Intermediates Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 51. Lonza Pharmaceutical Intermediates Product
Table 52. Lonza Recent Developments/Updates
Table 53. Catalent Corporation Information
Table 54. Catalent Description and Business Overview
Table 55. Catalent Pharmaceutical Intermediates Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 56. Catalent Pharmaceutical Intermediates Product
Table 57. Catalent Recent Developments/Updates
Table 58. Patheon Corporation Information
Table 59. Patheon Description and Business Overview
Table 60. Patheon Pharmaceutical Intermediates Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 61. Patheon Pharmaceutical Intermediates Product
Table 62. Patheon Recent Developments/Updates
Table 63. Jubilant Corporation Information
Table 64. Jubilant Description and Business Overview
Table 65. Jubilant Pharmaceutical Intermediates Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 66. Jubilant Pharmaceutical Intermediates Product
Table 67. Jubilant Recent Developments/Updates
Table 68. Granules Corporation Information
Table 69. Granules Description and Business Overview
Table 70. Granules Pharmaceutical Intermediates Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 71. Granules Pharmaceutical Intermediates Product
Table 72. Granules Recent Developments/Updates
Table 73. Ganesh Corporation Information
Table 74. Ganesh Description and Business Overview
Table 75. Ganesh Pharmaceutical Intermediates Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 76. Ganesh Pharmaceutical Intermediates Product
Table 77. Ganesh Recent Developments/Updates
Table 78. Chemcon Corporation Information
Table 79. Chemcon Description and Business Overview
Table 80. Chemcon Pharmaceutical Intermediates Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 81. Chemcon Pharmaceutical Intermediates Product
Table 82. Chemcon Recent Developments/Updates
Table 83. BASF Corporation Information
Table 84. BASF Description and Business Overview
Table 85. BASF Pharmaceutical Intermediates Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 86. BASF Pharmaceutical Intermediates Product
Table 87. BASF Recent Developments/Updates
Table 88. Porton Corporation Information
Table 89. Porton Description and Business Overview
Table 90. Porton Pharmaceutical Intermediates Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 91. Porton Pharmaceutical Intermediates Product
Table 92. Porton Recent Developments/Updates
Table 93. Lianhetech Corporation Information
Table 94. Lianhetech Description and Business Overview
Table 95. Lianhetech Pharmaceutical Intermediates Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 96. Lianhetech Pharmaceutical Intermediates Product
Table 97. Lianhetech Recent Developments/Updates
Table 98. ABA Chem Corporation Information
Table 99. ABA Chem Description and Business Overview
Table 100. ABA Chem Pharmaceutical Intermediates Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 101. ABA Chem Pharmaceutical Intermediates Product
Table 102. ABA Chem Recent Developments/Updates
Table 103. Tianma Corporation Information
Table 104. Tianma Description and Business Overview
Table 105. Tianma Pharmaceutical Intermediates Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 106. Tianma Pharmaceutical Intermediates Product
Table 107. Tianma Recent Developments/Updates
Table 108. Jiujiujiu Corporation Information
Table 109. Jiujiujiu Description and Business Overview
Table 110. Jiujiujiu Pharmaceutical Intermediates Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 111. Jiujiujiu Pharmaceutical Intermediates Product
Table 112. Jiujiujiu Recent Developments/Updates
Table 113. Alpha Corporation Information
Table 114. Alpha Description and Business Overview
Table 115. Alpha Pharmaceutical Intermediates Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 116. Alpha Pharmaceutical Intermediates Product
Table 117. Alpha Recent Developments/Updates
Table 118. Jiuzhou Corporation Information
Table 119. Jiuzhou Description and Business Overview
Table 120. Jiuzhou Pharmaceutical Intermediates Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 121. Jiuzhou Pharmaceutical Intermediates Product
Table 122. Jiuzhou Recent Developments/Updates
Table 123. Yongtai Corporation Information
Table 124. Yongtai Description and Business Overview
Table 125. Yongtai Pharmaceutical Intermediates Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 126. Yongtai Pharmaceutical Intermediates Product
Table 127. Yongtai Recent Developments/Updates
Table 128. Production Base and Market Concentration Rate of Raw Material
Table 129. Key Suppliers of Raw Materials
Table 130. Pharmaceutical Intermediates Distributors List
Table 131. Pharmaceutical Intermediates Customers List
Table 132. Pharmaceutical Intermediates Market Trends
Table 133. Pharmaceutical Intermediates Growth Drivers
Table 134. Pharmaceutical Intermediates Market Challenges
Table 135. Pharmaceutical Intermediates Market Restraints
Table 136. Global Pharmaceutical Intermediates Sales Forecast by Type (2022-2027) & (K MT)
Table 137. Global Pharmaceutical Intermediates Sales Market Share Forecast by Type (2022-2027)
Table 138. Global Pharmaceutical Intermediates Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 139. Global Pharmaceutical Intermediates Revenue Market Share Forecast by Type (2022-2027)
Table 140. Global Pharmaceutical Intermediates Sales Forecast by Application (2022-2027) & (K MT)
Table 141. Global Pharmaceutical Intermediates Sales Market Share Forecast by Application (2022-2027)
Table 142. Global Pharmaceutical Intermediates Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 143. Global Pharmaceutical Intermediates Revenue Market Share Forecast by Application (2022-2027)
Table 144. Global Pharmaceutical Intermediates Sales Forecast by Region (2022-2027) & (K MT)
Table 145. Global Pharmaceutical Intermediates Sales Market Share Forecast by Region (2022-2027)
Table 146. Global Pharmaceutical Intermediates Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 147. Global Pharmaceutical Intermediates Revenue Market Share Forecast by Region (2022-2027)
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pharmaceutical Intermediates
Figure 2. Global Pharmaceutical Intermediates Market Share by Type in 2020 & 2027
Figure 3. GMP Product Picture
Figure 4. Non-GMP Product Picture
Figure 5. Global Pharmaceutical Intermediates Market Share by Application in 2020 & 2027
Figure 6. Antibiotics
Figure 7. Antipyretic Analgesics
Figure 8. Vitamins
Figure 9. Others
Figure 10. Global Pharmaceutical Intermediates Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Pharmaceutical Intermediates Market Size 2016-2027 (US$ Million)
Figure 12. Global Pharmaceutical Intermediates Sales 2016-2027 (K MT)
Figure 13. Global Pharmaceutical Intermediates Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Pharmaceutical Intermediates Sales Share by Manufacturers in 2020
Figure 15. Global Pharmaceutical Intermediates Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Pharmaceutical Intermediates Players: Market Share by Revenue in 2020
Figure 17. Pharmaceutical Intermediates Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Pharmaceutical Intermediates Sales Market Share by Region (2016-2021)
Figure 19. Global Pharmaceutical Intermediates Sales Market Share by Region in 2020
Figure 20. Global Pharmaceutical Intermediates Revenue Market Share by Region (2016-2021)
Figure 21. Global Pharmaceutical Intermediates Revenue Market Share by Region in 2020
Figure 22. U.S. Pharmaceutical Intermediates Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Pharmaceutical Intermediates Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Pharmaceutical Intermediates Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Pharmaceutical Intermediates Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Pharmaceutical Intermediates Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Pharmaceutical Intermediates Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Pharmaceutical Intermediates Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Pharmaceutical Intermediates Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Pharmaceutical Intermediates Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Pharmaceutical Intermediates Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Pharmaceutical Intermediates Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Pharmaceutical Intermediates Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. China Taiwan Pharmaceutical Intermediates Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Pharmaceutical Intermediates Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Pharmaceutical Intermediates Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Pharmaceutical Intermediates Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Pharmaceutical Intermediates Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Pharmaceutical Intermediates Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Pharmaceutical Intermediates Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Pharmaceutical Intermediates Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Pharmaceutical Intermediates Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. UAE Pharmaceutical Intermediates Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Pharmaceutical Intermediates by Type (2016-2021)
Figure 45. Sales Market Share of Pharmaceutical Intermediates by Application (2016-2021)
Figure 46. Sales Market Share of Pharmaceutical Intermediates by Application in 2020
Figure 47. Revenue Share of Pharmaceutical Intermediates by Application (2016-2021)
Figure 48. Revenue Share of Pharmaceutical Intermediates by Application in 2020
Figure 49. Manufacturing Cost Structure of Pharmaceutical Intermediates
Figure 50. Manufacturing Process Analysis of Pharmaceutical Intermediates
Figure 51. Pharmaceutical Intermediates Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Lonza Catalent Patheon Jubilant Granules Ganesh Chemcon BASF Porton Lianhetech ABA Chem Tianma Jiujiujiu Alpha Jiuzhou Yongtai